Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Genomics and Diagnostics, Radiomics and Machine Learning in Medical Imaging, Cancer-related Molecular Pathways, and AI in cancer detection.
Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent features
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment
The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer
Deep learning generates synthetic cancer histology for explainability and education
Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations
An enhancer variant associated with breast cancer susceptibility in Black women regulates <i>TNFSF10</i> expression and antitumor immunity in triple-negative breast cancer
Racial disparities in survival outcomes among breast cancer patients by molecular subtypes
p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability
Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer
Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling
Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer
Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in <i>BRCA1</i> Mutation Carriers
Household air pollution and chronic hypoxia in the placenta of pregnant Nigerian women: A randomized controlled ethanol Cookstove intervention
A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer
β-catenin regulates<i>c-Myc</i>and<i>CDKN1A</i>expression in breast cancer cells
Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease
TNFR2 Activates MLCK-Dependent Tight Junction Dysregulation to Cause Apoptosis-Mediated Barrier Loss and Experimental Colitis
Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer
Regulation of Tcf7l1 DNA Binding and Protein Stability as Principal Mechanisms of Wnt/β-Catenin Signaling
Expression of Polycomb Targets Predicts Breast Cancer Prognosis
Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma